{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:04:36Z","timestamp":1789571076863,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neubiorev.2022.104647","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:07:13Z","timestamp":1648760833000},"page":"104647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: A systematic review"],"prefix":"10.1016","volume":"137","author":[{"given":"Xinchen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Ekheden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Hellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jan Hasselstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Jayaram-Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"M D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mataix-Cols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sidorchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2022.104647_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/945621","article-title":"Maternal characteristics of women exposed to hypnotic benzodiazepine receptor agonist during pregnancy","volume":"2014","author":"Askaa","year":"2014","journal-title":"Obstet. Gynecol. Int"},{"key":"10.1016\/j.neubiorev.2022.104647_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jad.2020.03.014","article-title":"Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: a systematic review and meta-analysis","volume":"269","author":"Bais","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2022.104647_bib3","first-page":"288","article-title":"Prescription patterns of benzodiazepine and benzodiazepine-related drugs in the peripartum period: a population-based study","author":"Bais","year":"2020","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104647_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.genhosppsych.2012.09.003","article-title":"Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview","volume":"35","author":"Bellantuono","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104647_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.1994.tb12076.x","article-title":"Early postnatal diazepam treatment of rats and neuroimmunocompetence in adulthood and senescence","volume":"717","author":"Benesova","year":"1994","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104647_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034829","article-title":"Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study","volume":"10","author":"Bloti\u00e8re","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.neubiorev.2022.104647_bib7","series-title":"Introduction to Meta-Analysis","first-page":"357","article-title":"When Does it Make Sense to Perform a Meta-Analysis?","author":"Borenstein","year":"2009"},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/ije\/dyv030","article-title":"Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings","volume":"44","author":"Brandlistuen","year":"2015","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.neubiorev.2022.104647_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1371\/journal.pone.0181042","article-title":"Association of prenatal exposure to benzodiazepines and child internalizing problems: a sibling-controlled cohort study","volume":"12","author":"Brandlistuen","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104647_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003081-200203000-00004","article-title":"Drug effects on the fetus and breast-fed infant","volume":"45","author":"Briggs","year":"2002","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.neubiorev.2022.104647_bib11","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104647_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1192\/bjp.bp.113.143693","article-title":"Fetal growth and psychiatric and socioeconomic problems: population-based sibling comparison","volume":"205","author":"Class","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104647_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1542\/peds.2020-044131","article-title":"Maternal adverse childhood experiences and child behavior problems: a systematic review","volume":"148","author":"Cooke","year":"2021","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00002018-200932040-00004","article-title":"Managing epilepsy in women of childbearing age","volume":"32","author":"Crawford","year":"2009","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104647_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jrsm.37","article-title":"A further use for the Harvest plot: a novel method for the presentation of data synthesis","volume":"2","author":"Crowther","year":"2011","journal-title":"Res Synth. Methods"},{"issue":"9","key":"10.1016\/j.neubiorev.2022.104647_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25854","article-title":"Association of maternal depressive symptoms during the perinatal period with oppositional defiant disorder in children and adolescents","volume":"4","author":"Dachew","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neubiorev.2022.104647_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamanetworkopen.2020.25570","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with intellectual disability and delayed childhood milestones","volume":"3","author":"Daugaard","year":"2020","journal-title":"JAMA Netw. OPEN"},{"issue":"Suppl 1","key":"10.1016\/j.neubiorev.2022.104647_bib18","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.2105\/AJPH.2013.301252","article-title":"Critical need for family-based, quasi-experimental designs in integrating genetic and social science research","volume":"103","author":"D\u2019Onofrio","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neubiorev.2022.104647_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-clinpsy-032816-045030","article-title":"Accounting for confounding in observational studies","volume":"16","author":"D\u2019Onofrio","year":"2020","journal-title":"Annu Rev. Clin. Psychol."},{"issue":"11","key":"10.1016\/j.neubiorev.2022.104647_bib20","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1177\/1087054720914386","article-title":"Parental prenatal symptoms of depression and offspring symptoms of ADHD: a genetically informed intergenerational study","volume":"25","author":"Eilertsen","year":"2021","journal-title":"J. Atten. Disord."},{"issue":"10","key":"10.1016\/j.neubiorev.2022.104647_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00787-014-0558-3","article-title":"Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review","volume":"23","author":"El Marroun","year":"2014","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104647_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamaneurol.2017.5035","article-title":"Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children","volume":"75","author":"Elkjaer","year":"2018","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104647_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","article-title":"The fetal safety of benzodiazepines: an updated meta-analysis","volume":"33","author":"Enato","year":"2011","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"8","key":"10.1016\/j.neubiorev.2022.104647_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","article-title":"Use of antidepressants during pregnancy and risk of attention-deficit\/hyperactivity disorder in the offspring","volume":"31","author":"Figueroa","year":"2010","journal-title":"J. Dev. Behav. Pedia"},{"key":"10.1016\/j.neubiorev.2022.104647_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.genhosppsych.2018.05.010","article-title":"Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: results from a prospective registry of women with psychiatric disorders","volume":"53","author":"Freeman","year":"2018","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104647_bib26","doi-asserted-by":"crossref","first-page":"f6409","DOI":"10.1136\/bmj.f6409","article-title":"Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research","volume":"347","author":"Freemantle","year":"2013","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.neubiorev.2022.104647_bib27","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1523\/JNEUROSCI.5663-11.2012","article-title":"Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding","volume":"32","author":"Gielen","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104647_bib28","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"key":"10.1016\/j.neubiorev.2022.104647_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4088\/JCP.18r12412","article-title":"Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis","volume":"80","author":"Grigoriadis","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104647_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"10.1016\/j.neubiorev.2022.104647_bib31","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1089\/jwh.2019.8199","article-title":"A cohort study of psychotropic prescription drug use in pregnancy in British Columbia, Canada from 1997 to 2010","volume":"29","author":"Hanley","year":"2020","journal-title":"J. Women\u2019s. Health"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104647_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.apnu.2019.04.001","article-title":"A practical guide to the use of psychotropic medications during pregnancy and lactation","volume":"33","author":"Hardy","year":"2019","journal-title":"Arch. Psychiatr. Nurs."},{"issue":"14","key":"10.1016\/j.neubiorev.2022.104647_bib33","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJM197504032921405","article-title":"Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality","volume":"292","author":"Hartz","year":"1975","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2022.104647_bib34","series-title":"Psychiatric Disorders in Pregnancy and the Postpartum: Principles and Treatment","author":"Hendrick","year":"2006"},{"key":"10.1016\/j.neubiorev.2022.104647_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1371\/journal.pone.0219778","article-title":"Use and validity of child neurodevelopment outcome measures in studies on prenatal exposure to psychotropic and analgesic medications - a systematic review","volume":"14","author":"Hjorth","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neubiorev.2022.104647_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1001\/jamanetworkopen.2020.5860","article-title":"Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway","volume":"3","author":"Huitfeldt","year":"2020","journal-title":"JAMA Netw. OPEN"},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104647_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.braindev.2009.02.006","article-title":"Triggers of apoptosis in the immature bran","volume":"31","author":"Ikonomidou","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.neubiorev.2022.104647_bib38","doi-asserted-by":"crossref","unstructured":"Jeste, S.S. (2015). Neurodevelopmental behavioral and cognitive disorders. Continuum (Minneap Minn) 21(3 Behavioral Neurology and Neuropsychiatry): 690\u2013714.","DOI":"10.1212\/01.CON.0000466661.89908.3c"},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104647_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00737-009-0100-7","article-title":"Zolpidem (Ambien) in pregnancy: placental passage and outcome","volume":"12","author":"Juric","year":"2009","journal-title":"Arch. Women\u2019s. Ment. Health"},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104647_bib40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/026119290703500610","article-title":"Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility","volume":"35","author":"Knight","year":"2007","journal-title":"Alter. Lab Anim."},{"issue":"12","key":"10.1016\/j.neubiorev.2022.104647_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/bdr2.1077","article-title":"Use of psychotropic medications in breastfeeding women","volume":"109","author":"Kronenfeld","year":"2017","journal-title":"Birth Defects Res"},{"issue":"17","key":"10.1016\/j.neubiorev.2022.104647_bib42","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2016.16435","article-title":"Confounding by indication in clinical research","volume":"316","author":"Kyriacou","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104647_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2008-1071314","article-title":"Neurodevelopment in late infancy after prenatal exposure to benzodiazepines - a prospective study","volume":"23","author":"Laegreid","year":"1992","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104647_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0963721410383977","article-title":"All in the family: comparing siblings to test causal hypotheses regarding environmental influences on behavior","volume":"19","author":"Lahey","year":"2010","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104647_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acps.12479","volume":"445","author":"Larsen","year":"2015","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104647_bib46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40263-020-00728-2","article-title":"Associations of prescribed ADHD medication in pregnancy with pregnancy-related and offspring outcomes: a systematic review","volume":"34","author":"Li","year":"2020","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104647_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.neubiorev.2022.104647_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1001\/jamanetworkopen.2019.1435","article-title":"Association of maternal use of benzodiazepines and Z-hypnotics during pregnancy with motor and communication skills and attention-deficit\/hyperactivity disorder symptoms in preschoolers","volume":"2","author":"Lupattelli","year":"2019","journal-title":"JAMA Netw. OPEN"},{"key":"10.1016\/j.neubiorev.2022.104647_bib49","doi-asserted-by":"crossref","unstructured":"Martin, C.E., C. Mak, C. Miller, C. Welsh and M. Terplan (2015). \"Trends in Drug-exposed Deliveries From 2002 to 2009.\" Addictive Disorders & Their Treatment 14(2): 61\u201369.","DOI":"10.1097\/ADT.0000000000000044"},{"key":"10.1016\/j.neubiorev.2022.104647_bib50","doi-asserted-by":"crossref","unstructured":"Mattson, S.N., K.E. Calarco, C.D. Chambers and K.L. Jones (2002). \"Interaction of maternal smoking and other in-pregnancy exposures: Analytic considerations.\" Special Issue: Festschrift in honour of Peter Fried. 24(3): 359\u2013367.","DOI":"10.1016\/S0892-0362(02)00198-8"},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104647_bib51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0269881117699361","article-title":"British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017","volume":"31","author":"McAllister-Williams","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2022.104647_bib52","unstructured":"McKenzie, J.E., S.E. Brennan (2021). Chapter 12: Synthesizing and presenting findings using other methods. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. www.training.cochrane.org\/handbook. J. P. T. Higgins, J. Thomas, J. Chandler et al."},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104647_bib53","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejvs.2018.02.017","article-title":"Major Sources of Bias","volume":"55","author":"Meuli","year":"2018","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104647_bib54","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1176\/ajp.2006.163.6.1026","article-title":"Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications","volume":"163","author":"Misri","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2022.104647_bib55","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1023\/A:1025306304635","article-title":"Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics","volume":"18","author":"Mortensen","year":"2003","journal-title":"Eur. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104647_bib56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.biopsych.2020.08.029","article-title":"Elevated polygenic burden for autism spectrum disorder is associated with the broad autism phenotype in mothers of individuals with autism spectrum disorder","volume":"89","author":"Nayar","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2022.104647_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(03)01729-1","article-title":"Long-lasting behavioral changes induced by pre- or neonatal exposure to diazepam in rats","volume":"469","author":"Nicosia","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104647_bib58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/bfm.2020.0259","article-title":"Benzodiazepine concentrations in the breast milk and plasma of nursing mothers: estimation of relative infant dose","volume":"16","author":"Nishimura","year":"2021","journal-title":"Breast Med"},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104647_bib59","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.4088\/JCP.14m09240","article-title":"Neurodevelopment of children prenatally exposed to selective reuptake inhibitor antidepressants: Toronto sibling study","volume":"76","author":"Nulman","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104647_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00228-014-1797-4","article-title":"Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age","volume":"71","author":"Odsbu","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2022.104647_bib61","first-page":"3","article-title":"Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: A case-control study using a claims database in Japan ASIA-PACIFIC","volume":"10","author":"Ogawa","year":"2018","journal-title":"PSYCHIATRY"},{"key":"10.1016\/j.neubiorev.2022.104647_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2288-8-8","article-title":"The harvest plot: a method for synthesising evidence about the differential effects of interventions","volume":"8","author":"Ogilvie","year":"2008","journal-title":"BMC Med. Res. Method."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1750-3639.2002.tb00467.x","article-title":"Drug-induced apoptotic neurodegeneration in the developing brain","volume":"12","author":"Olney","year":"2002","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2022.104647_bib64","unstructured":"Page, M.J., J.P. T. Higgins, J.A. C. Sterne (2021). Chapter 13: Assessing risk of bias due to missing results in a synthesis. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org\/handbook. J. P. T. Higgins, J. Thomas, J. Chandler et al."},{"key":"10.1016\/j.neubiorev.2022.104647_bib65","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104647_bib66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","article-title":"The most commonly dispensed prescription medications among pregnant women enrolled in the U.S. Medicaid Program","volume":"126","author":"Palmsten","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.neubiorev.2022.104647_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/297153","article-title":"Alterations of GABAergic signaling in autism spectrum disorders","volume":"2011","author":"Pizzarelli","year":"2011","journal-title":"Neural Plast."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104647_bib68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12884-021-03787-5","article-title":"Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007-2015","volume":"21","author":"Qato","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.neubiorev.2022.104647_bib69","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ntt.2017.02.005","article-title":"Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study","volume":"61","author":"Radoj\u010di\u0107","year":"2017","journal-title":"Neurotoxicol.Teratol."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib70","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/add.12808","article-title":"Benzodiazepine use among mothers of small children: a register-based cohort study","volume":"110","author":"Raitasalo","year":"2015","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/imhj.10025","article-title":"Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads","volume":"23","author":"Reebye","year":"2002","journal-title":"Infant Ment. Health J."},{"key":"10.1016\/j.neubiorev.2022.104647_bib72","first-page":"3","article-title":"Affect expression and self-regulation capacities of infants exposed in utero to psychotropics","author":"Reebye","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104647_bib73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmjopen-2012-002166","article-title":"Combined use of selective serotonin reuptake inhibitors and sedatives\/hypnotics during pregnancy: Risk of relatively severe congenital malformations or cardiac defects. A register study","volume":"3","author":"Reis","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104647_bib74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/npp.2014.147","article-title":"Developmental consequences of fetal exposure to drugs: what we know and what we still must learn","volume":"40","author":"Ross","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2022.104647_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10802-016-0161-9","article-title":"Maternal prenatal psychological distress and preschool cognitive functioning: the protective role of positive parental engagement","volume":"45","author":"Schechter","year":"2017","journal-title":"J. Abnorm Child Psychol."},{"issue":"1","key":"10.1016\/j.neubiorev.2022.104647_bib76","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/GRF.0000000000000417","article-title":"Benzodiazepines in pregnancy","volume":"62","author":"Shyken","year":"2019","journal-title":"Clin. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.neubiorev.2022.104647_bib77","first-page":"1095","article-title":"Behavioural effects of prenatal diazepam administration on anxiety patterns in rats.\"","volume":"34","author":"Singh","year":"1996","journal-title":"Indian J. Exp. Biol."},{"issue":"6","key":"10.1016\/j.neubiorev.2022.104647_bib78","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF01967827","article-title":"Effects of drug administration in pregnancy on children\u2019s school behaviour","volume":"12","author":"Stika","year":"1990","journal-title":"Pharm. Weekbl. Sci. Ed."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jcpp.13004","article-title":"Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research","volume":"60","author":"Sujan","year":"2019","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104647_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1371\/journal.pone.0217830","article-title":"Impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age: a study from the Norwegian Mother and Child Cohort Study","volume":"14","author":"Sundbakk","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2215-0366(16)30376-5","article-title":"Neurodevelopmental disorders","volume":"4","author":"Thapar","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2022.104647_bib82","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pds.3495","article-title":"Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk","volume":"22","author":"Thorpe","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"10","key":"10.1016\/j.neubiorev.2022.104647_bib83","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bdr2.1497","article-title":"Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997\u20132011","volume":"111","author":"Tinker","year":"2019","journal-title":"Birth Defects Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104647_bib84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104647_bib85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1469-7610.1993.tb00993.x","article-title":"Mental development in late infancy after prenatal exposure to benzodiazepines: a prospective study","volume":"34","author":"Viggedal","year":"1993","journal-title":"Child Psychol. Psychiatry Allied Discip."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104647_bib86","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1430","article-title":"Benzodiazepines and the Z-drugs in pregnancy-reasonably reassuring for neurodevelopment but should we really be using them","volume":"2","author":"Vigod","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104647_bib87","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/JCP.0b013e3182197055","article-title":"Are hypnotic benzodiazepine receptor agonists teratogenic in humans?","volume":"31","author":"Wikner","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2022.104647_bib88","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamapsychiatry.2017.2733","article-title":"Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes","volume":"74","author":"Yonkers","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104647_bib89","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.neubiorev.2022.104647_bib90","article-title":"GABaergic system dysfunction in autism spectrum disorders","volume":"9","author":"Zhao","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.neubiorev.2022.104647_bib91","unstructured":"Wells, G., B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, P. Tugwell., 2000 The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.neubiorev.2022.104647_bib92","doi-asserted-by":"crossref","unstructured":"Zucker, I. (2017). Risk mitigation for children exposed to drugs during gestation: A critical role for animal preclinical behavioral testing Neuroscience and biobehavioral reviews 77(oa7, 7806090): 107\u2013121.","DOI":"10.1016\/j.neubiorev.2017.03.005"},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104647_bib93","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00213-018-4873-0","article-title":"Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing","volume":"235","author":"Zucker","year":"2018","journal-title":"Psychopharmacology"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:08:29Z","timestamp":1758967709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763422001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":93,"alternative-id":["S0149763422001361"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104647","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104647"}}